NCT06553989 Impact on Quality of Life of Osteopathic Visceral Mobilizations After Endometriosis Surgery
| NCT ID | NCT06553989 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Clermont-Ferrand |
| Condition | Endometriosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 63 participants |
| Start Date | 2025-01-27 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 63 participants in total. It began in 2025-01-27 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
One of the most common post-operative complications of gynaecological surgery, and in particular endometriosis surgery, is the formation of peritoneal adhesions. After laparotomy, it affects up to 90% of patients. Minimally invasive techniques (such as laparoscopy) reduce the risk of adhesion formation, but cannot totally prevent it. Adhesions can lead to chronic pelvic pain, dyspareunia, digestive disorders and infertility. Various strategies and devices have been developed to try and limit adhesion formation, but their effectiveness has not been fully proven in the literature. The only real treatment for adhesions is adhesiolysis, although adhesions often reform. The quality of surgery remains the best means of preventing adhesion formation. To reduce the morbidity associated with pelvic adhesions, it is essential to develop alternative, non-invasive, anti-adhesive methods such as manual osteopathic visceral mobilization.
Eligibility Criteria
Inclusion Criteria: * Woman of legal age * Indication for surgery for infiltrating endometriosis * Able to give informed consent to participate in research * Patient included in NO ENDO (national endometriosis observatory promoted by Clermont-Ferrand University Hospital) Exclusion Criteria: * Indication for surgery for superficial endometriosis * Patient of legal age, under guardianship or trusteeship * Pregnant or breast-feeding patient * Patients not affiliated to the social security system * Patients who do not speak French * Patients under court protection * Simultaneous participation in another study * Refusal to participate.
Contact & Investigator
Nicolas Bourdel
PRINCIPAL INVESTIGATOR
University Hospital, Clermont-Ferrand
Frequently Asked Questions
Who can join the NCT06553989 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Endometriosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06553989 currently recruiting?
Yes, NCT06553989 is actively recruiting participants. Contact the research team at promo_interne_drci@chu-clermontferrand.fr for enrollment information.
Where is the NCT06553989 trial being conducted?
This trial is being conducted at Clermont-Ferrand, France.
Who is sponsoring the NCT06553989 clinical trial?
NCT06553989 is sponsored by University Hospital, Clermont-Ferrand. The principal investigator is Nicolas Bourdel at University Hospital, Clermont-Ferrand. The trial plans to enroll 63 participants.